Adial Pharmaceuticals, Inc · NASDAQ:ADIL
Armistice Capital, LLC's stake in Adial Pharmaceuticals, Inc fell to 4.99% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Armistice Capital, LLC's stake in Adial Pharmaceuticals, Inc fell to 4.99%, 274,139 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 4.99%
- Shares
- 274,139
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 4.99% | 274,139 |
| Steven Boyd | 4.99% | 274,139 |
Source
Related
- Adial Pharmaceuticals, Inc
- Armistice Capital, LLC
- Adial Pharmaceuticals, Inc shareholders
- Form 4 · Coastlands Capital LP · Jul 16, 2026
- Form 4 · Coastlands Capital LP · Jul 13, 2026
- Form 4 · Coastlands Capital LP · Jul 1, 2026
- Schedule 13G/A · Coastlands Capital LP · Jul 1, 2026
- Schedule 13G · Coastlands Capital LP · Jun 24, 2026